A
Avadel Pharmaceuticals - ADR (AVDL)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Avadel Pharmaceuticals - ADR (AVDL)
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcole... Read more
- USD15.89
- USD17.85
- USD15.65
- USD19.09
- 8.90%
- 26M
- 4.21M
- 1.11M
- 1.8B
- 9.50
- 21.50%
Stock News
1 hour ago
Building on Greatness: Redesigned Toyota Camry Goes All-Hybrid at Kentucky Plant
Yahoo
1 hour ago
Accel Entertainment Announces Q1 2024 Operating Results
Yahoo
1 hour ago
Hennessy Advisors, Inc. Reports 25% Increase in Quarterly Earnings Per Share and Announces Quarterly Dividend
Yahoo
1 hour ago
UGI Corporation Announces Final Remarketing Period for its Series A Cumulative Perpetual Convertible Preferred Stock Relating to its 2021 Equity Units Offering
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
